Agilent Technologies Announces Senior Notes Offering

Details

announced it has entered into an underwriting agreement to issue $600 million in aggregate principal amount of 4.200% Senior Notes due 2027 and $600 million in aggregate principal amount of 4.750% Senior Notes due 2034. The offering is expected to close on September 9, 2024, with the 2027 Notes issued at 99.866% of their principal amount and the 2034 Notes at 99.638%. The notes will bear interest at fixed rates of 4.200% and 4.750% per annum, payable semi-annually.

Items reported

Exhibits (2)

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.